---
$id: https://graph.org.ai/products/commodity/51161552
$type: Product
source: UNSPSC
code: "51161552"
title: "Pirolate"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pirolate

**UNSPSC Code**: 51161552
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C16H15N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2LF7L6QD58, chemically known as pyrimido(4,5-b)quinoline-2-carboxylic acid, 1,4-dihydro-7,8-dimethoxy-4-oxo-, ethyl ester but generally known as pirolate, which bears US NIH Compound Identifier 5361200. European Medicines Agency schedules Pirolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09932MIG. The term PIROLATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). PIROLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirolate under HS 29335995 and SITC 51576. As of Q4 2014, PIROLATE remains the US FDA Preferred Term for this commodity. Pirolate bears US NLM identifiers UMLS ID C2826064 and NCI Concept Code C82231. SMILES: O(C1CC2C(NC3[NH]C(NC(=O)C3C2)C(=O)OCC)CC1OC)C.

